Increased exposure through product in Germany wont hurtMedipharm in the long run. Almost tripling product approvals is a good start to 2024
"Thus far in 2024, MediPharm has increased the German product approvals under the Beacon Medical brand from 5 to 14" Lets see if Medipharm numbers increase substantially from last years financial reporting at this time Most of MediPharm’s sales in the January-March quarter were in Canada.
"By jurisdiction, the company’s revenue was:
- CA$3.9 million in Canada.
- CA$51,000 in Australia.
- CA$1.2 million in Germany.
- CA$575,000 in other, unspecified places.
MediPharm’s sales in the Canadian adult-use and wellness sector were C$3.5 million in the first quarter, up from CA$2.5 million in the same period last year.
International medical cannabis sales amounted to CA$1.8 million, up from CA$1.3 million in the first quarter last year."